AI assistant
Sending…
METLIFE INC — Director's Dealing 2017
Mar 2, 2017
29995_dirs_2017-03-02_0deb51ca-9ee4-4059-9ae2-55087c1b71db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-02-28
Reporting Person: Lee Esther (EVP & Chief Marketing Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-28 | Employee Stock Option (Right to Buy) | $52.44 | A | 14303 | Acquired | 2027-02-27 | Common Stock (14303) | Direct |
| 2017-02-28 | Restricted Stock Units | $ | A | 4768 | Acquired | Common Stock (4768) | Direct |
Footnotes
F1: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020.
F2: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.
F3: The Restricted Units vest in three equal installments on the first business day in March 2018, 2019 and 2020.
More from METLIFE INC
Notice of Dividend Amount
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19